MedTrace Logo

Adaptive Optics ScanningLaser Ophthalmoscope Safety and Efficacy Clinical Trial

NCT06173414 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 194

Last updated 2023-12-15

No results posted yet for this study

Summary

This prospective, multicenter, single-group, target-value clinical trial was designed to evaluate the efficacy and safety of an Adaptive Optics ScanningLaser Ophthalmoscope(AOSLO) for ophthalmic examination.

Conditions

  • Retinal Disease
  • Healthy

Interventions

OTHER

No intervention measures

No intervention measures

Sponsors & Collaborators

  • Robotrak Technologies Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Qian Liu, O.D. · Henan Provincial Eye Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-05
Primary Completion
2023-10-31
Completion
2023-11-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06173414 on ClinicalTrials.gov